Market closed

Eledon Pharmaceuticals/$ELDN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Eledon Pharmaceuticals

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Ticker

$ELDN
Trading on

Industry

Biotechnology

Employees

31
Website

ELDN Metrics

BasicAdvanced
$189M
-
-$0.75
0.81
-
$189M
0.81
$4.44
$3.07
12.415
12.108
0.542
0.808
-33.11%
-57.73%
1.6
2.2
-3.245
-84.25%
-31.59%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ELDN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Eledon Pharmaceuticals stock?

Eledon Pharmaceuticals (ELDN) has a market cap of $189M as of April 05, 2025.

What is the P/E ratio for Eledon Pharmaceuticals stock?

The price to earnings (P/E) ratio for Eledon Pharmaceuticals (ELDN) stock is 0 as of April 05, 2025.

Does Eledon Pharmaceuticals stock pay dividends?

No, Eledon Pharmaceuticals (ELDN) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Eledon Pharmaceuticals dividend payment date?

Eledon Pharmaceuticals (ELDN) stock does not pay dividends to its shareholders.

What is the beta indicator for Eledon Pharmaceuticals?

Eledon Pharmaceuticals (ELDN) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.